Jag Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.3M | Sell |
26,123
-95,304
| -78% | -$12.6M | 0.31% | 49 |
|
|
2026
Q1 | $16.9M | Buy |
121,427
+9,326
| +8% | +$1.31M | 1.9% | 20 |
|
|
2025
Q4 | $13.8M | Buy |
+112,101
| New | +$13.6M | 1.49% | 27 |
|
|
2024
Q1 | – | Sell |
-16,235
| Closed | -$1.32M | – | 142 |
|
|
2023
Q4 | $1.32M | Buy |
16,235
+90
| +0.6% | +$7K | 0.2% | 60 |
|
|
2023
Q3 | $1.21M | Buy |
16,145
+618
| +4% | +$47.5K | 0.15% | 91 |
|
|
2023
Q2 | $1.2M | Buy |
15,527
+253
| +2% | +$20.2K | 0.14% | 94 |
|
|
2023
Q1 | $1.27M | Sell |
15,274
-1,332
| -8% | -$110K | 0.16% | 90 |
|
|
2022
Q4 | $1.43M | Buy |
16,606
+2,224
| +15% | +$176K | 0.21% | 84 |
|
|
2022
Q3 | $887K | Sell |
14,382
-31
| -0.2% | -$1.96K | 0.12% | 107 |
|
|
2022
Q2 | $891K | Sell |
14,413
-4,400
| -23% | -$272K | 0.11% | 112 |
|
|
2022
Q1 | $1.22M | Buy |
18,813
+2,855
| +18% | +$182K | 0.12% | 94 |
|
|
2021
Q4 | $1.16M | Sell |
15,958
-29
| -0.2% | -$2K | 0.09% | 107 |
|
|
2021
Q3 | $1.12M | Sell |
15,987
-3,392
| -18% | -$238K | 0.09% | 105 |
|
|
2021
Q2 | $1.33M | Buy |
19,379
+46
| +0.2% | +$3.07K | 0.1% | 104 |
|
|
2021
Q1 | $1.25M | Sell |
19,333
-523
| -3% | -$33.7K | 0.11% | 95 |
|
|
2020
Q4 | $1.16M | Sell |
19,856
-1,022
| -5% | -$61.7K | 0.1% | 97 |
|
|
2020
Q3 | $1.32M | Buy |
20,878
+592
| +3% | +$41.1K | 0.14% | 86 |
|
|
2020
Q2 | $1.56M | Sell |
20,286
-154,468
| -88% | -$11.8M | 0.18% | 75 |
|
|
2020
Q1 | $13.1M | Buy |
174,754
+160,303
| +1,109% | +$11.1M | 1.93% | 19 |
|
|
2019
Q4 | $939K | Buy |
14,451
+37
| +0.3% | +$2.41K | 0.11% | 123 |
|
|
2019
Q3 | $914K | Sell |
14,414
-1,463
| -9% | -$95.6K | 0.11% | 116 |
|
|
2019
Q2 | $1.07M | Buy |
15,877
+218
| +1% | +$14.3K | 0.12% | 111 |
|
|
2019
Q1 | $1.02M | Buy |
15,659
+95
| +0.6% | +$6.31K | 0.17% | 67 |
|
|
2018
Q4 | $974K | Sell |
15,564
-945
| -6% | -$66.1K | 0.2% | 67 |
|
|
2018
Q3 | $1.27M | Buy |
16,509
+28
| +0.2% | +$2.12K | 0.21% | 63 |
|
|
2018
Q2 | $1.17M | Buy |
16,481
+63
| +0.4% | +$4.45K | 0.2% | 64 |
|
|
2018
Q1 | $1.24M | Hold |
16,418
| – | – | 0.23% | 65 |
|
|
2017
Q4 | $1.18M | Sell |
16,418
-1,065
| -6% | -$80.9K | 0.22% | 69 |
|
|
2017
Q3 | $1.42M | Buy |
17,483
+225
| +1% | +$17.2K | 0.27% | 69 |
|
|
2017
Q2 | $1.22M | Buy |
17,258
+1,830
| +12% | +$122K | 0.24% | 69 |
|
|
2017
Q1 | $1.05M | Sell |
15,428
-1,320
| -8% | -$92.8K | 0.22% | 76 |
|
|
2016
Q4 | $1.2M | Hold |
16,748
| – | – | 0.24% | 73 |
|
|
2016
Q3 | $1.32M | Sell |
16,748
-225
| -1% | -$18.3K | 0.26% | 71 |
|
|
2016
Q2 | $1.42M | Buy |
16,973
+36
| +0.2% | +$3.19K | 0.31% | 70 |
|
|
2016
Q1 | $1.56M | Sell |
16,937
-139,778
| -89% | -$12.6M | 0.32% | 63 |
|
|
2015
Q4 | $15.9M | Sell |
156,715
-9,107
| -5% | -$948K | 2.96% | 10 |
|
|
2015
Q3 | $16.3M | Sell |
165,822
-1,877
| -1% | -$208K | 3.09% | 16 |
|
|
2015
Q2 | $18.6M | Buy |
167,699
+62,160
| +59% | +$6.79M | 3.39% | 8 |
|
|
2015
Q1 | $10.4M | Sell |
105,539
-85,327
| -45% | -$8.66M | 1.86% | 25 |
|
|
2014
Q4 | $18M | Buy |
190,866
+2,734
| +1% | +$283K | 3.31% | 8 |
|
|
2014
Q3 | $20M | Sell |
188,132
-17,745
| -9% | -$1.74M | 4.02% | 2 |
|
|
2014
Q2 | $17.1M | Buy |
205,877
+102,021
| +98% | +$7.94M | 3.33% | 7 |
|
|
2014
Q1 | $7.36M | Buy |
103,856
+71,346
| +219% | +$5.6M | 1.51% | 28 |
|
|
2013
Q4 | $2.44M | Sell |
32,510
-1,855
| -5% | -$129K | 0.49% | 40 |
|
|
2013
Q3 | $2.16M | Buy |
34,365
+1,076
| +3% | +$64.3K | 0.48% | 42 |
|
|
2013
Q2 | $1.71M | Buy |
+33,289
| New | +$1.74M | 0.42% | 44 |
|
Other funds holding GILD
Jag Capital Management's GILD Position: Q2 2026 in Review
Jag Capital Management reduced its Gilead Sciences (GILD) stake by 78% in Q2 2026, selling an estimated $12.6M and leaving 26,123 shares worth $3.3M. The position accounts for 0.31% of the portfolio, ranked #49.
Jag Capital Management first reported a position in GILD in Q2 2013 and has held it in 46 quarters since. The position peaked at $20M in Q3 2014. 1,032 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Jag Capital Management held 26,123 shares of Gilead Sciences worth $3.3M as of Q2 2026.
- Jag Capital Management sold 95,304 Gilead Sciences shares in Q2 2026, an estimated $12.6M.
- Gilead Sciences made up 0.31% of Jag Capital Management's portfolio in Q2 2026, its #49 holding.
- Jag Capital Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 46 quarters since.
- Jag Capital Management's Gilead Sciences position peaked at $20M in Q3 2014.
- 1,032 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Jag Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.